NCT04125459View on ClinicalTrials.gov

Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout

Active, not recruitingOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

October 3, 2024

Conditions
Gout
Interventions
PROCEDURE

Joint Biopsy

a synovial biopsy of a joint that has been affected by a gout attack

Trial Locations (1)

90211

Attune Health Research Inc., Beverly Hills

All Listed Sponsors
collaborator

Horizon Pharma Ireland, Ltd., Dublin Ireland

INDUSTRY

lead

Attune Health Research, Inc.

INDUSTRY